Skip to content

CSD FARMAKEM

Active Private limited companyfounded 2009active for 17 yearsElvire Boelensstraat 7, 9160 LokerenKBO/BCE: BE 0811.756.574

Lifetime

15 annual accounts with figures on one time axis
peak of €123,307 in 2013
€103,380▲ 46.6%
lowest -€28,520 in 2009
€65,982▲ 59.0%
peak of €268,699 in 2025
€268,699▲ 31.4%
€15,448▼ 15.8%
Board1 name since 2024
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €70,519 to €103,380Result from €41,507 to €65,982Dividend €1,700Equity from €204,417 to €268,699Debts from €18,348 to €15,448Cash from €9,220 to €16,653

Key points

from the 2025 annual accounts

Equity

€268,699 ▲ 31.4%

CSD FARMAKEM has made a profit without a break since 2016.

Filings

15 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Nine of the last ten came late. The 2014 accounts came in latest, 1,239 days after the end of the period.

Position in the sector

94.6%

Higher solvency than 93% of companies in head offices and management consultancy. The sector median is 55.5%, over 41,316 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,733 companies had the same profile as CSD FARMAKEM has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,733 companies, not a prediction for CSD FARMAKEM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 26-05-2009
  • 100 sharesdeed of 26-05-2009

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0811756574
changes role from manager to director Discharge granted to · Gazette deed
Strikeout withdrawal effective 21-02-2019 · KBO administration
Incorporation Founding capital of €20,000, 200 shares, €8,000 paid up · Founded by and · appointed as manager · published on 26-05-2009 · Gazette deed
All 30 events

Comparable companies

same main activity, similar in size and age
Company
CSD FARMAKEM Lokeren €284,147 €103,380 94.6% -
A-Buildit Sint-Niklaas €318,290 €103,736 57.9% -
RIVAGO Denderleeuw €307,216 €92,817 51.7% -
Manaut Maarkedal €306,292 €96,313 83.7% -
PRO + Beveren-Kruibeke-Zwijndrecht €241,656 €97,730 70.8% -
cubeway Gavere €312,909 €113,015 78.0% -
Co+ Ghent €284,140 €98,478 78.8% -

These companies have the same main activity as CSD FARMAKEM: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €242,000 and €318,000, founded between 2007 and 2011.

Official details

Source: KBO
Status
Active since 15-05-2009Normal situation
Activity
Business and other management consultancyNACE 70200and 1 other
Establishment unit
2.179.120.8369160 Lokeren, since 13-05-2009
Financial year end
31 December
Peppol
Reachable since 26-02-2025
Company details

Annual accounts 2025

≈ €170,000estimated
€284,147▲ 27.6%
Filing
Filed on 31-08-2026
Financials

Insights on CSD FARMAKEM

CSD FARMAKEM files the micro format. That format states no turnover. The gross margin rose from -€26,334 in 2009 to €103,380 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CSD FARMAKEM

What is the company number of CSD FARMAKEM?
The company number of CSD FARMAKEM is 0811.756.574. The VAT number is the same number with BE in front: BE 0811.756.574.
Where is CSD FARMAKEM based?
The registered office is at Elvire Boelensstraat 7, 9160 Lokeren.Company details
What does CSD FARMAKEM do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of CSD FARMAKEM?
CSD FARMAKEM is a private limited company (BV).
When was CSD FARMAKEM founded?
CSD FARMAKEM was founded on 15-05-2009.
Is CSD FARMAKEM still active?
Yes, CSD FARMAKEM is an active enterprise in the KBO register.
What is the turnover of CSD FARMAKEM?
The turnover in financial year 2025 is about €170,000. This figure is estimated from the gross margin of €103,380 and 123 comparable companies (NACE 70200). It probably lies between €150,000 and €200,000.Financials
Is CSD FARMAKEM profitable?
In financial year 2025, CSD FARMAKEM made a profit of €65,982.
Where can I find the annual accounts of CSD FARMAKEM?
CSD FARMAKEM filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CSD FARMAKEM due?
CSD FARMAKEM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.